Delivering unique monoclonal antibodies of extreme specificity

SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds and complex antigens. 

 

Either as a custom service,

or as a catalog product,

you can benefit

from SYnAbs technologies

to get access to 

unique monoclonal antibodies.

 




In SYnAbs they trust


The benefits of SYnAbs technologies?

  1. Extreme specificity monoclonal antibodies
  2. Higher affinity monoclonal antibodies
  3. Excellent results for small, difficult and poor immunogenic antigens
  4. Additional epitope recognition
  5. High and stable producer clones
  6. Access to multiple immune repertoires
  7. Raising antibodies against difficult to express antigens
  8. Generating antibodies against conformation sensitive targets


SYnAbs 2020 agenda

Feb 3rd- Feb 6th

Feb 4th - Feb 5th

Feb 5th - Feb 6th

March 26th - March 27th

May 28th

June 8th - June 11th

June 10th - June 11th 

July 26th - July 30th

Nov 11th - Nov 13th

Nov 16th - Nov 19th

Dec 10th

 

Dubai, Emirates, Medlab

Evreux, France, Polepharma Biotesting Day

Strasbourg, France, Bioproduction Buzz4Bio 

Ghent, Belgium, Translational Immunology

Ghent, Belgium, Knowledge for Growth

San Diego, USA, BIO International Convention

Oxford, United Kingdom, Pivotal Scientific

Chicago, USA, AACC

Oxford, United Kingdom, HAH

Dusseldorf, Germany, MEDICA

Louvain-la-Neuve, Belgium, BioWin Day